Adrian R. Krainer, Director at Stoke Therapeutics, Inc. (STOK), sold 80,944 shares at $29.72 ($2.4M) on 2025-11-24, disclosed to the SEC on 2025-11-26.
Scheduled sale ($2.4M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.72 | 40,472 | $1.2M | 50.0% |
| 2 | $29.72 | 40,472 | $1.2M | 50.0% |
| Total | $29.72 avg | 80,944 | $2.4M | 100% |
| Filing → |
| STOK | SELL | 2025-11-18 | $2.2M | — | Filing → |